-
VYGR Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Voyager Therapeutics (VYGR)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 115.40 mm | 115.40 mm | 115.40 mm | 115.40 mm | 115.40 mm | 115.40 mm |
Cash burn (monthly) | (no burn) | (no burn) | 4.59 mm | (no burn) | 9.32 mm | 2.05 mm |
Cash used (since last report) | n/a | n/a | 24.31 mm | n/a | 49.35 mm | 10.82 mm |
Cash remaining | n/a | n/a | 91.09 mm | n/a | 66.05 mm | 104.57 mm |
Runway (months of cash) | n/a | n/a | 19.8 | n/a | 7.1 | 51.1 |
13F holders | Current |
---|---|
Total holders | 130 |
Opened positions | 24 |
Closed positions | 22 |
Increased positions | 43 |
Reduced positions | 37 |
13F shares | Current |
---|---|
Total value | 187.62 bn |
Total shares | 43.08 mm |
Total puts | 60.40 k |
Total calls | 6.00 k |
Total put/call ratio | 10.1 |
Largest owners | Shares | Value |
---|---|---|
NBIX Neurocrine Biosciences | 8.58 mm | $59.34 mm |
Armistice Capital | 5.40 mm | $30.60 bn |
BlackRock | 5.36 mm | $30.37 bn |
EcoR1 Capital | 3.92 mm | $22.21 bn |
Vanguard | 3.22 mm | $18.23 bn |
Farallon Capital Management | 2.57 mm | $14.58 bn |
Dimensional Fund Advisors | 1.38 mm | $7.83 bn |
Vestal Point Capital | 1.23 mm | $6.97 bn |
Geode Capital Management | 1.08 mm | $6.15 bn |
Erste Asset Management GmbH | 1.06 mm | $5.94 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 Feb 25 | Toby Ferguson | Common Stock | Grant | Acquire A | No | No | 0 | 63,000 | 0.00 | 168,000 |
21 Feb 25 | Toby Ferguson | Stock Option Common Stock | Grant | Acquire A | No | No | 4.22 | 126,000 | 531.72 k | 126,000 |
21 Feb 25 | Sandell Jacquelyn Fahey | Common Stock | Grant | Acquire A | No | No | 0 | 41,500 | 0.00 | 123,143 |
21 Feb 25 | Sandell Jacquelyn Fahey | Stock Option Common Stock | Grant | Acquire A | No | No | 4.22 | 83,000 | 350.26 k | 83,000 |
21 Feb 25 | Nathan D. Jorgensen | Common Stock | Grant | Acquire A | No | No | 0 | 51,500 | 0.00 | 131,500 |
21 Feb 25 | Nathan D. Jorgensen | Stock Option Common Stock | Grant | Acquire A | No | No | 4.22 | 103,000 | 434.66 k | 103,000 |
21 Feb 25 | Robin Swartz | Common Stock | Grant | Acquire A | No | No | 0 | 71,250 | 0.00 | 169,647 |
21 Feb 25 | Robin Swartz | Stock Option Common Stock | Grant | Acquire A | No | No | 4.22 | 142,500 | 601.35 k | 142,500 |
21 Feb 25 | Todd Alfred Carter | Common Stock | Grant | Acquire A | No | No | 0 | 46,000 | 0.00 | 123,718 |
21 Feb 25 | Todd Alfred Carter | Stock Option Common Stock | Grant | Acquire A | No | No | 4.22 | 92,000 | 388.24 k | 92,000 |